newsfilter
← Latest News
GlobeNewswire·

Arch Biopartners Adds Farris Smith as a Strategic Advisor

TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Today, Arch Biopartners Inc., ("Arch" or the "Company") (TSXV:ARCH, OTCQB:ACHFF), a clinical stage company focused on the development of innovative technologies and novel therapeutics targeting organ inflammat